Pharmaceuticals and personal care products in untreated and treated sewage sludge: Occurrence and environmental risk in the case of application on soil - A critical review

Science of the Total Environment

Volumn 538, Issue , 2015, Pages 750-767

  Verlicchi, P ^a,b   Zambello, E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Technopole Terra and Acqua Tech   (Italy)

Author keywords

Environmental risk; Personal care products; Pharmaceuticals; Sewage sludge; Sludge amended soil

Indexed keywords

ANAEROBIC DIGESTION; ANTIBIOTICS; DRUG PRODUCTS; RISK ASSESSMENT; SEWAGE SLUDGE; SLUDGE DISPOSAL; SOILS; WASTEWATER DISPOSAL; WASTEWATER TREATMENT; WATER TREATMENT;

ENVIRONMENTAL RISK ASSESSMENT; ENVIRONMENTAL RISKS; EUROPEAN COUNTRIES; MUNICIPAL WASTEWATER TREATMENT PLANTS; PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; SLUDGE CONCENTRATION; SLUDGE-AMENDED SOILS;

SLUDGE DIGESTION;

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CAFFEINE; CHEMICALS AND DRUGS; CIPROFLOXACIN; ESTRADIOL; HORMONE; OFLOXACIN; PHARMACEUTICAL AND PERSONAL CARE PRODUCT; TETRACYCLINE; TRICLOCARBAN; TRICLOSAN; UNCLASSIFIED DRUG; COSMETIC; DRUG; SEWAGE; SOIL; WASTE WATER; WATER POLLUTANT;

AGRICULTURE; ENVIRONMENTAL RISK; PPCP; RISK ASSESSMENT; SEWAGE; SLUDGE; SOIL AMENDMENT;

AGRICULTURAL WASTE; COMPOSTING; CONCENTRATION (PARAMETERS); DIGESTED SLUDGE; ENVIRONMENTAL FACTOR; EUROPE; LAGOON SLUDGE; LEGAL PROCEDURE; MIXED SLUDGE; MUNICIPAL SOLID WASTE; OXIDATION REDUCTION STATE; PH; PREDICTION; PRIMARY SLUDGE; PRIORITY JOURNAL; RAW SLUDGE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY SLUDGE; SLUDGE; SLUDGE TREATMENT; SOIL AMENDMENT; SOIL ANALYSIS; SOIL POLLUTION; SOIL TREATMENT; UNITED STATES; URBAN AREA; WASTE WATER TREATMENT PLANT; AGRICULTURE; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; PROCEDURES; SEWAGE; SOIL; WASTE WATER; WATER POLLUTANT;

EUROPE; UNITED STATES;

AGRICULTURE; COSMETICS; ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEWAGE; SOIL; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84940434636     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.08.108     Document Type: Review

References (113)

1. Andersen H., Siegrist H., Halling-Sørensen B., Ternes T.A. Fate of estrogens in a municipal sewage treatment plant. Environ. Sci. Technol. 2003, 37:4021-4026.
2. Andersen H.R., Hansen M., Kjølholt J., Stuer-Lauridsen F., Ternes T., Halling-Sørensen B. Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. Chemosphere 2005, 61(1):139-146.
3. Arthurson V. Proper sanitization of sewage sludge: a critical issue for a sustainable society. Appl. Environ. Microbiol. 2008, 74(17):5267-5275.
4. Braga O., Smythe G.A., Schäfer A.I., Feitz A.J. Fate of steroid estrogens in Australian inland and coastal wastewater treatment plants. Environ. Sci. Technol. 2005, 39:3351-3358.
5. Butler E., Whelan M.J., Ritz K., Sakrabani R., Van Egmond R. Effects of triclosan on soil microbial respiration. Environ. Toxicol. Chem. 2011, 30(2):360-366.
6. Carballa M., Omil F., Alder A.C., Lema J.M. Comparison between the conventional anaerobic digestion of sewage sludge and its combination with a chemical or thermal pre-treatment concerning the removal of pharmaceuticals and personal care products. Water Sci. Technol. 2006, 53(8):109-117.
7. Carballa M., Manterola G., Larrea L., Ternes T., Omil F., Lema J.M. Influence of ozone pre-treatment on sludge anaerobic digestion: removal of pharmaceutical and personal care products. Chemosphere 2007, 67(7):1444-1452.
8. Carballa M., Omil F., Lema J.M. Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceutical and personal care products (PPCPs). Environ. Sci. Technol. 2007, 41:884-890.
9. Carballa M., Omil F., Ternes T., Lema J.M. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Res. 2007, 41:2139-2150.
10. Carballa M., Fink G., Omil F., Lema J.M., Ternes T. Determination of the solid-water distribution coefficient (kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. Water Res. 2008, 42(1-2):287-295.
11. CEC (Council of the European Communities) Council Directive 91/271/EEC of May 21, 1991 concerning urban wastewater treatment. O.J. 30 May, 1991, 135.
12. CEC (Council of the European Communities), Council Directive 86/278/EEC of 12 June 1986 on the protection of the environment, and in particular of the soil, when sewage sludge is used in agriculture. Official J L 181:0006:0012.
13. CEC (Council of the European Communities), Council Directive 99/31/EC of 26 April 1999 on the landfill of waste. O.J. 182/1 16 July 1999.
14. Chu S., Metcalfe C.D. Simultaneous determination of triclocarban and triclosan in municipal biosolids by liquid chromatography tandem mass spectrometry. J. Chromatogr. A 2007, 1164:212-218.
15. Citulski J.A., Farahbakhsh K. Fate of endocrine-active compounds during municipal biosolids treatment: a review. Environ. Sci. Technol. 2010, 44(22):8367-8376.
16. Clara M., Strenn B., Saracevic E., Kreuzinger N. Adsorption of bisphenol-A, 17β-estradiole and 17α-ethinylestradiole to sewage sludge. Chemosphere 2004, 56(9):843-851.
17. Clara M., Gans O., Windhofer G., Krenn U., Hartl W., Braun K., Scharf S., Scheffknecht C. Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment. Chemosphere 2011, 82(8):1116-1123.
18. Clarke B.O., Smith S.R. Review of 'emerging' organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ. Int. 2011, 37:226-247.
19. Cunningham V.L. Special characteristics of pharmaceuticals related to environmental fate. Pharmaceutical in the environment - Sources, fate, effects and risks 2008, 23-34. Springer-Verlag, Berlin, Heidelberg. III ed. K. Kummerer (Ed.).
20. Cunningham V.L., D'aco V.J., Pfeiffer D., Anderson P.D., Buzby M.E., Jahnke J., Hannah R.E., Parke N.J. Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the phate tm model. Integr. Environ. Assess. Manag. 2012, 8(3):530-542.
21. Diaz-Cruz M.S., García-Galán M.J., Guerra P., Jelic A., Postigo C., Eljarrat E., Farré M., López de Alda M.J., Petrovic M., Barceló D. Analysis of selected emerging contaminants in sewage sludge. TrAC Trends Anal. Chem. 2009, 28(11):1263-1275.
22. Directive 2000/60/EC of October 23, 2000 of the European Parliamanet and of the Council establishing a framework for community action in the field of water policy O.J. Decembre 22, 2000, 327. (FWD).
23. Drillia P., Stamatelatou K., Lyberatos G. Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 2005, 60:1034-1044.
24. EC (European Commission), Working Document on sludge and biowaste, available at the site: , Working document on Sludge and Biowaste 21st September 2010 (Last access July, 13th 2015). http://www.dwa.de/portale/ewa/ewa.
25. EC-TGD Technical Guidance Document on Risk Assessment, Part II, EUR 20418 EN/2. European Commission, Joint Research Centre 2003.
26. Eggen T., Majcherczyk A. Removal of polycyclic aromatic hydrocarbons (PAH) in contaminated soil by white rot fungus pleurotus ostreatus. Int. Biodeterior. Biodegrad. 1998, 41(2):111-117.
27. Eriksen G.S., Amundsen C.E., Bernhoft A., Eggen T., Grave K., Halling-Sørensen B., et al. Risk assessment of contaminants in sewage sludge applied on Norwegian soils. Norway: Panel on Contaminants in the Norwegian Scientific Committee for Food Safety 2009.
28. Eriksson E., Christensen N., Ejbye Schmidt J., Ledin A. Potential priority pollutants in sewage sludge. Desalination 2008, 226:371-388.
29. Fernandez-Fontaina E., Pinho I., Carballa M., Omil F., Lema J.M. Biodegradation kinetic constants and sorption coefficients of micropollutants in membrane bioreactors. Biodegradation 2013, 24(2):165-177.
30. Gao L., Shi Y., Li W., Niu H., Liu J., Cai Y. Occurrence of antibiotics in eight sewage treatment plants in Beijing, China. Chemosphere 2012, 86:665-671.
31. Gao P., Ding Y., Li H., Xagoraraki I. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: Mass balance and removal processes. Chemosphere 2012, 88:17-24.
32. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39(3981):9.
33. Golet E.M., Strehler A., Alder A.C., Giger W. Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Anal. Chem. 2002, 74:5455-5462.
34. Golet E., Xifra I., Siegrist H., Alder A., Giger W. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ. Sci. Technol. 2003, 37:3243-3249.
35. Heidler J., Halden R.U. Fate of organohalogens in US wastewater treatment plants and estimated chemical releases to soils nationwide from biosolids recycling. J. Environ. Monit. 2009, 11:2207-2215.
36. Heidler J., Sapkota A., Halden R.U. Partitioning, persistence, and accumulation in digested sludge of the topical antiseptic triclocarban during wastewater treatment. Environ. Sci. Technol. 2006, 40(11):3634-3639.
37. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
38. Horsing M., Ledin A., Grabic R., Fick J., Tysklind M., Jansen J.L.C., Andersen H.R. Determination of sorption of seventy-five pharmaceuticals in sewage sludge. Water Res. 2011, 45(15):4470-4482.
39. Hyland K.C., Dickenson E.R.V., Drewes J.E., Higgins C.P. Sorption of ionized and neutral emerging trace organic compounds onto activated sludge from different wastewater treatment configurations. Water Res. 2012, 46(6):1958-1968.
40. Inglezakis V.J., Zorpas A.A., Karagiannidis A., Samaras P., Voukkali I., Sklari S. European Union legislation on sewage sludge management. Fresenius Environ. Bull. 2014, 23:635-639.
41. Jelic A., Gros M., Ginebreda A., Cespedes-Sánchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
42. Jelic A., Fatone F., Di Fabio S., Petrovic M., Cecchi F., Barcelo D. Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment. Sci. Total Environ. 2012, 433:352-361.
43. Jia A., Wan Y., Xiao Y., Hu J. Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant. Water Res. 2012, 46:387-394.
44. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 2002, 36(20):5013-5022.
45. Jones V., Gardner M., Ellor B. Concentrations of trace substances ins ewage sludge from 28 wastewater works in UK. Chemosphere 2014, 111:478-484.
46. Jones-Lepp T.L., Stevens R. Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation. Anal. Bioanal. Chem. 2007, 387:1173-1183.
47. Karickhoff S.W. Semiempirical estimation of sorption of hydrophobic pollutants on natural sediments and soils. Chemosphere 1981, 10:833-846.
48. Kelessidis A., Stasinakis A.S. Comparative study of the methods used for treatment and final disposal of sewage sludge in European countries. Waste Manag. 2012, 32(6):1186-1195.
49. Khan S.J., Ongerth J.E. Estimation of pharmaceutical residues in primary and secondary sewage sludge based on quantities of use and fugacity modeling. Water Sci. Technol. 2002, 46:105-113.
50. Kimura K., Hara H., Watanabe Y. Elimination of selected pharmaceuticals by biosolids from municipal wastewater treatment plants: Importance of modest pH change and degree of mineralization. Water Sci. Technol. 2010, 62(5):1084-1089.
51. Kinney C.A., Furlong E.T., Zaugg S.D., Burkhardt M.R., Werner S.L., Cahill J.D., Jorgensen G.R. Survey of organic wastewater contaminants in biosolids destined for land application. Environ. Sci. Technol. 2006, 40:7207-7215.
52. Kinney C.A., Furlong E.T., Kolpin D.W., Burkhardt M.R., Zaugg S.D., Werner S.L., Bossio J.P., Benotti M.J. Bioaccumulation of pharmaceuticals and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environ. Sci. Technol. 2008, 42(6):1863-1870.
53. Kloepper-Sams P., Torfs F., Feijtel T., Gooch J. Effects assessments for surfactants in sludge-amended soils: a literature review and perspectives for terrestrial risk assessment. Sci. Total Environ. 1996, 185(1-3):171-185.
54. Kummerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J. Environ. Manag. 2009, 90(8):2354-2366.
55. Lajeunesse A., Smyth S.A., Barclay K., Sauvé S., Gagnon C. Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada. Water Res. 2012, 46:5600-5612.
56. Li W.C. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil. Environ. Pollut. 2014, 187:193-201.
57. Lillenberg M., Yurchenko S., Kipper K., Herodes K., Pihl V., Sepp K., Nei L. Simultaneous determination of fluoroquinolones, sulfonamides and tetracyclines in sewage sludge by pressurized liquid extraction and liquid chromatography electrospray ionization-mass spectrometry 2009, 1216:5949-5954.
58. Lindberg R.H., Wennberg P., Johansson M.I., Tysklind M., Andersson B.A.V. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ. Sci. Technol. 2005, 39:3421-3429.
59. Lindberg R.H., Olofsson U., Rendahl P., Johansson M.I., Tysklind M., Andersson B.A.V. Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge. Environ. Sci. Technol. 2006, 40:1042-1048.
60. Lindberg R.H., Fick J., Tysklind M. Screening of antimycotics in Swedish sewage treatment plants - waters and sludge. Water Res. 2010, 44:649-657.
61. Mailler R., Gasperi J., Chebbo G., Rocher V. Priority and emerging pollutants in sewage sludge and fate during sludge treatment. Waste Manag. 2014, 34(7):1217-1226.
62. Malmborg J., Magnér J. Pharmaceutical residues in sewage sludge: effect of sanitization and anaerobic digestion. J. Environ Manag. 2015, 153:1-10.
63. Maoz A., Chefetz B. Sorption of the pharmaceuticals carbamazepine and naproxen to dissolved organic matter: role of structural fractions. Water Res. 2010, 44(3):981-989.
64. Martin J., Camacho-Muñoz D., Santos J.L., Aparicio I., Alonso E. Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. risk assessment of sludge application onto soils. J. Environ. Manag. 2012, 102:18-25.
65. Martin J., Camacho-Muñoz D., Santos J.L., Aparicio I., Alonso E. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: Removal and ecotoxicological impact of wastewater discharges and sludge disposal. J. Hazard. Mater. 2012, 239-240:40-47.
66. Martin J., Santos J.L., Aparicio I., Alonso E. Pharmaceutically active compounds in sludge stabilization treatments: anaerobic and aerobic digestion, wastewater stabilization ponds and composting. Sci. Total Environ. 2015, 503-504:97-104.
67. Matter-Muller C., Gujer W., Giger W., Stumm W. Non-biological elimination mechanisms in biological sewage treatment plant. Prog. Water Technol. 1980, 12:299-314.
68. McAvoy D.C., Schatowitz B., Jacob M., Hauk A., Eckhoff W.S. Measurement of triclosan in wastewater treatment systems. Environ. Toxicol. Chem. 2002, 21:1323-1329.
69. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Res. 2010, 44:658-668.
70. Metcalfe Eddy Wastewater engineering: treatment and reuse 2004, Mc Graw Hill, Singapore. Fourth ed.
71. Miao X., Yang J., Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ. Sci. Technol. 2005, 39:7469-7475.
72. Monteiro S.C., Boxall A.B. Occurrence and fate of human pharmaceuticals in the environment. Rev. Environ. Contam. Toxicol. 2010, 202:53-154.
73. Muller M., Rabenoelina F., Balaguer P., Patureau D., Lemenach K., Budzinski H., et al. Chemical and biological analysis of endocrine-disrupting hormones and estrogenic activity in an advanced sewage treatment plant. Environ. Toxicol. Chem. 2008, 27(8):1649-1658.
74. Muller M., Combalbert S., Delgenès N., Bergheaud V., Rocher V., Benoît P., et al. Occurrence of estrogens in sewage sludge and their fate during plant-scale anaerobic digestion. Chemosphere 2010, 81(1):65-71.
75. Munoz I., Gómez-Ramos M.J., Agüera A., Fernández-Alba A.R., García-Reyes J.F., Molina-Díaz A. Chemical evaluation of contaminants in wastewater effluents and the environmental risk of reusing effluents in agriculture. TrAC Trends Anal. Chem. 2009, 28(6):676-694.
76. Nieto A., Borrull F., Pocurull E., Marcé R.M. Occurrence of pharmaceuticals and hormones in sewage sludge. Environ. Toxicol. Chem. 2010, 29(7):1484-1489.
77. Okuda T., Yamashita N., Tanaka H., Matsukawa H., Tanabe K. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants. Environ. Int. 2009, 35(5):815-820.
78. Osemwengie L.I. Determination of synthetic musk compounds in sewage biosolids by gas chromatography/mass spectrometry. J. Environ. Monit. 2006, 8:897-903.
79. Palfrey R. Progress on revision of the EU Sludge Directive. Water and Sewerage Journal 2010, Features. From WRc: http://www.wrcplc.co.uk/1progresson-revision-of-the-eu-sewage-sludge-directive-water-sewerage-september-2010-.aspx (Last access July, 13th 2015).
80. Paterakis N., Chiu T.Y., Koh Y.K.K., Lester J.N., McAdam E.J., Scrimshaw M.D., Soares A., Cartmell E. The effectiveness of anaerobic digestion in removing estrogens and nonylphenol ethoxylates. J. Hazard. Mater. 2012, 199-200:88-95.
81. Peysson W., Vulliet E. Determination of 136 pharmaceuticals and hormones in sewage sludge using quick, easy, cheap, effective, rugged and safe extraction followed by analysis with liquid chromatography-time-of-flight-mass spectrometry. J. Chromatogr. A 2013, 1290:46-61.
82. Pomiès M., Choubert J., Wisniewski C., Coquery M. Modelling of micropollutant removal in biological wastewater treatments: a review. Sci. Total Environ. 2013, 443:733-748.
83. Radjenović J., Jelić A., Petrović M., Barceló D. Determination of pharmaceuticals in sewage sludge by pressurized liquid extraction (PLE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS). Anal. Bioanal. Chem. 2009, 393:1685-1695.
84. Radjenović J., Petrović M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43(3):831-841.
85. Redshaw C.H., Cooke M.P., Talbot H.M., McGrath S., Rowland S.J. Low biodegradability of fluoxetine HCl, diazepam and their human metabolites in sewage sludge-amended soil. J. Soils Sediments 2008, 8(4):217-230.
86. Rogers H.R. Sources, behaviour and fate of organic contaminants during sewage treatment and in sewage sludges. Sci. Total Environ. 1996, 185(1-3):3-26.
87. Sarmah A.K., Northcott G.L., Scherr F.F. Retention of estrogenic steroid hormones by selected New Zealand soils. Environ. Int. 2008, 34:749-755.
88. Sathyamoorthy S., Ramsburg C.A. Assessment of quantitative structural property relationships for prediction of pharmaceutical sorption during biological wastewater treatment. Chemosphere 2013, 92(6):639-646.
89. Scheurer M., Ramil M., Metcalfe C.D., Groh S., Ternes T.A. The challenge of analyzing beta-blocker drugs in sludge and wastewater. Anal. Bioanal. Chem. 2010, 396(2):845-856.
90. Sim W., Lee J., Shin S., Song K., Oh J. Assessment of fates of estrogens in wastewater and sludge from various types of wastewater treatment plants. Chemosphere 2011, 82:1448-1453.
91. Stasinakis A.S. Review on the fate of emerging contaminants during sludge anaerobic digestion. Bioresour. Technol. 2012, 121:432-440.
92. Stasinakis A.S., Gatidou G., Mamais D., Thomaidis N.S., Lekkas T.D. Occurrence and fate of endocrine disrupters in Greek sewage treatment plants. Water Res. 2008, 42(6-7):1796-1804.
93. Stasinakis A.S., Kordoutis C.I., Tsiouma V.C., Gatidou G., Thomaidis N.S. Removal of selected endocrine disrupters in activated sludge systems: effect of sludge retention time on their sorption and biodegradation. Bioresour. Technol. 2010, 101(7):2090-2095.
94. Stasinakis A.S., Thomaidis N.S., Arvaniti O.S., Asimakopoulos A.G., Samaras V.G., Ajibola A., Mamais D., Lekkas T.D. Contribution of primary and secondary treatment on the removal of benzothiazoles, benzotriazoles, endocrine disruptors, pharmaceuticals and perfluorinated compounds in a sewage treatment plant. Sci. Total Environ. 2013, 463-464:1067-1075.
95. Stevens J.L., Northcott G.L., Stern G.A., Tomy G.T., Jones K.C. PAHs, PCBs, PCNs, organochlorine pesticides, synthetic musks, and polychlorinated n-alkanes in U.K. sewage sludge: survey results and implications. Environ. Sci. Technol. 2003, 37(3):462-467.
96. Stevens-Garmon J., Drewes J.E., Khan S.J., McDonald J.A., Dickenson E.R.V. Sorption of emerging trace organic compounds onto wastewater sludge solids. Water Res. 2011, 45(11):3417-3426.
97. Subedi B., Lee S., Moon H., Kannan K. Emission of artificial sweeteners, select pharmaceuticals, and personal care products through sewage sludge from wastewater treatment plants in Korea. Environ. Int. 2014, 68:33-40.
98. Tavazzi S., Locoro G., Comero S., Sobiecka E., Loos R., Eder P., et al. Occurrence and levels of selected compounds in European compost and digestate samples. Report EUR 26164 EN 2013.
99. Ternes T.A., Joss A. Human pharmaceuticals, hormones and fragrances. The challenge of micropollutants in urban water management 2006, IWA Publishing, London.
100. Ternes T.A., Herrmann N., Bonerz M., Knacker T., Siegrist H., Joss A. A rapid method to measure the solid-water distribution coefficient (K d) for pharmaceuticals and musk fragrances in sewage sludge. Water Res. 2004, 38(19):4075-4084.
101. Thiele-Bruhn S. Pharmaceutical antibiotic compounds in soils - a review. J. Plant Nutr. Soil Sci. 2003, 166(2):145-167.
102. US E.P.A. Targeted national sewage sludge survey sampling and analysis technical report. EPA-822-R-08-016 2009, (Washington, DC.).
103. USA Code Part 503: . Last Access July, 13th 2015. http://www.ecfr.gov/cgi-bin/text-idx?tpl=/ecfrbrowse/Title40/40cfr503_main_02.tpl.
104. Vazquez-Roig P., Andreu V., Blasco C., Picó Y. Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego-Oliva marshlands (Valencia, Eastern Spain). Sci. Total Environ. 2012, 440:24-32.
105. Venkatesan A.K., Done H.Y., Halden R.U. United States National Sewage Sludge Repository at Arizona State University-a new resource and research tool for environmental scientists, engineers, and epidemiologists. Environ. Sci. Pollut. Res. 2014, 22:1577-1586.
106. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012, 429:123-155.
107. Verlicchi P., Zambello E., Al Aukidy M. Removal of pharmaceuticals by conventional wastewater treatment plants. Analysis Removal Effects and Risk of Pharmaceuticals in the Water Cycle. Comprehensive Analytical Chemistry 2013, Vol. 62:231-286. Barcelò D. (Elsevier), Amsterdam: The Netherlands. M. Petrovic, S. Suarez, D. Barcelò (Eds.).
108. von der Ohe P.C., Dulio V., Slobodnik J., De Deckere E., Kühne R., Ebert R., Ginebreda A., De Cooman W., Schüürmann G., Brack W. A new risk assessment approach for the prioritization of 500 classical and emerging organic microcontaminants as potential river basin specific pollutants under the European water framework directive. Sci. Total Environ. 2011, 409(11):2064-2077.
109. Xia K., Bhandari A., Das K., Pillar G. Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J. Environ. Qual. 2005, 34(1):91-104.
110. Xu W., Zhang G., Li X., Zou S., Li P., Hu Z., Li J. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Res. 2007, 41:4526-4534.
111. Yan Q., Gao X., Chen Y., Peng X., Zhang Y., Gan X., Zi C., Guo J. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir area. Sci. Total Environ. 2014, 470-471:618-630.
112. Ying G.G., Kookana R.S. Triclosan in wastewaters and biosolids from Australian wastewater treatment plants. Environ. Int. 2007, 33(2):199-205.
113. Zhu S., Chen H. The fate and risk of selected pharmaceutical and personal care products in wastewater treatment plants and a pilot-scale multistage constructed wetland system. Environ. Sci. Pollut. Res. 2014, 21(2):1466-1479.